ETNB 89bio Inc

USD 6.90 +0.28 ( +4.23%)
Icon

89bio Inc (ETNB) Financial Statements

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 6.90

+0.28 (+4.23%)

USD 1.18B

0.89M

USD 22.57(+227.12%)

USD 4.93 (-28.55%)

Icon

ETNB

89bio Inc (USD)
COMMON STOCK | NSD
USD 6.90
+0.28 ( +4.23%)

89bio Inc (ETNB) Annual Income Statement (USD)

ETNB Quarterly Financials (USD)

Frequently Asked Questions About 89bio Inc (ETNB) Stock

89bio Inc's (ETNB) last reported annual revenue was USD 0.00.

89bio Inc's (ETNB) annual revenue growth rate based on the revenue reported in the past 5 years is : N/A

89bio Inc's(ETNB) is not profitable as of its last reported annual financials.

The net profit margin for 89bio Inc's(ETNB) from its laster reported year is N/A

The return on equity (ROE) for 89bio Inc's(ETNB) from its last reported annual financials is : -78.34%

The return on assets (ROA) for 89bio Inc's(ETNB) from its last reported annual financials is : -44.73%

The return on invested capital (ROIC) for 89bio Inc's(ETNB) from its last reported annual financials is : -76.98%

The Debt to Equity ratio for 89bio Inc's(ETNB) from its last reported annual financials is : 8.92%

The dividend yield for 89bio Inc's(ETNB) from its laster reported year is 0.00%

89bio Inc's(ETNB) has negative cash flow as of its last reported annual financials.

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...